Aprocitentan
CAS No. 1103522-45-7
Aprocitentan( ACT-132577 )
Catalog No. M21083 CAS No. 1103522-45-7
Aprocitentan is ETA and ETB antagonist .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 138 | In Stock |
|
| 5MG | 112 | In Stock |
|
| 10MG | 169 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 431 | In Stock |
|
| 100MG | 642 | In Stock |
|
| 200MG | 868 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAprocitentan
-
NoteResearch use only, not for human use.
-
Brief DescriptionAprocitentan is ETA and ETB antagonist .
-
DescriptionAprocitentan is ETA and ETB antagonist .(In Vitro):Aprocitentan (ACT-132577) achieves full inhibition of intracellular calcium increase induced by ET-1 on nonrecombinant cells (primary human pulmonary smooth muscle cells and rat aortic smooth muscle cell line A10 and mouse fibroblast cell line 3T3).(In Vivo):Aprocitentan (ACT-132577) has a volume of distribution greater than the plasma volume and a longer half-life than its parent compound in the rat. In rat plasma, the mean recovery of Aprocitentan (ACT-132577) ranges from 82.6% to 90.6%, matrix effect of Aprocitentan (ACT-132577) in rat plasma ranges from 101.4% to 115.2%.
-
In VitroAprocitentan (ACT-132577) achieves full inhibition of intracellular calcium increase induced by ET-1 on nonrecombinant cells (primary human pulmonary smooth muscle cells and rat aortic smooth muscle cell line A10 and mouse fibroblast cell line 3T3).
-
In VivoAprocitentan (ACT-132577) has a volume of distribution greater than the plasma volume and a longer half-life than its parent compound in the rat. In rat plasma, the mean recovery of Aprocitentan (ACT-132577) ranges from 82.6% to 90.6%, matrix effect of Aprocitentan (ACT-132577) in rat plasma ranges from 101.4% to 115.2%.
-
SynonymsACT-132577
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorET-A |ET-B
-
Research AreaCardiovascular Disease
-
IndicationResistant Hypertension
Chemical Information
-
CAS Number1103522-45-7
-
Formula Weight546.19
-
Molecular FormulaC16H14Br2N6O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:46 mg/mL (84.22 mM)
-
SMILESNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1
-
Chemical NameN-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]sulfuric diamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
sn-Glycerol 3-phosph...
Glycerol 3-phosphate is produced by the reduction of dihydroxyacetone phosphate by NADH formed during glycolysis of the cytoplasmic glycerol 3-phosphate dehydrogenase pathway.
-
Ebaresdax hydrochlor...
Ebaresdax hydrochloride has analgesic activity and is used in the study of painful diabetic neuropathy caused by type I or type II diabetes.
-
Glutaric acid
Glutaric acid is a simple five-carbon linear dicarboxylic acid. Glutaric acid is naturally produced in the body during the metabolism of some amino acids including lysine and tryptophan. Glutaric acid may cause irritation to the skin and eyes. When present in sufficiently high levels glutaric acid can act as an acidogen and a metabotoxin.
Cart
sales@molnova.com